Nordex (NDX1) Q3 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 TU earnings summary
12 Dec, 2025Executive summary
Full-year 2025 EBITDA margin guidance was upgraded to 7.5%-8.5% following strong Q3 results and improved operational execution in both projects and service segments.
Q3 2025 showed strong profitability, with EBITDA margin rising to 8% from 4.3% last year, and management remains confident in delivering higher profitability for the remainder of 2025.
Free cash flow generation remains robust, totaling EUR 298 million year-to-date, with expectations for continued positive cash flow in Q4.
Margin improvement attributed to better project execution, faster-than-expected service recovery, stable supply chain, and disciplined pricing.
No major one-offs; margin improvement seen as underlying operational performance.
Financial highlights
Q3 2025 revenue was EUR 1,706 million, stable year-over-year; 9M 2025 sales at EUR 5,014 million, down 2% year-over-year.
Q3 2025 EBITDA was EUR 136 million (8.0% margin), up from EUR 72 million (4.3%) in Q3 2024; 9M 2025 EBITDA at EUR 324 million (6.5% margin), up 71% year-over-year.
Free cash flow in Q3 2025 exceeded EUR 72 million, with 9M 2025 FCF at EUR 298 million, up over 100% year-over-year.
Cash at end of Q3 2025 was EUR 1,378 million, up from EUR 1,151 million at end of Q4 2024.
Outlook and guidance
2025 EBITDA margin guidance raised to 7.5%-8.5%, with sales guidance at EUR 7.4–7.9 billion.
Working capital ratio expected to remain below -9%; CAPEX guidance maintained at approximately EUR 200 million.
Confident in delivering another year of strong free cash flow, though no formal guidance provided.
All other elements of guidance remain unchanged.
2026 outlook not yet provided; planning ongoing, with more clarity expected early next year.
Latest events from Nordex
- Record 2025 order intake, margin expansion, and new shareholder return policy drive growth.NDX1
Q4 202525 Feb 2026 - EBITDA margin improved to 3.4% in H1 2024, with strong sales and positive cash flow.NDX1
Q2 20243 Feb 2026 - EBITDA margin turned positive and sales rose 14% YoY, with guidance reaffirmed.NDX1
Q3 202416 Jan 2026 - Record order intake, margin recovery, and strong cash flow set stage for further growth in 2025.NDX1
Q4 202415 Dec 2025 - Q1 2025 delivered higher margins, positive cash flow, and strong order growth.NDX1
Q1 202529 Nov 2025 - Net income rebounded, margins improved, and order intake surged, supporting a strong outlook.NDX1
Q2 202516 Nov 2025 - Strong Q3 2025 growth in orders, profits, and cash flow led to a raised margin outlook.NDX1
Q3 20254 Nov 2025